A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis Grant uri icon

abstract

  • A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis.To evaluate the safety and tolerability of multiple ascending intravenous (IV) doses of ATYR1923 in patients with pulmonary sarcoidosis.To assess the potential steroid-sparing effect of multiple ascending doses of ATYR1923 in patients with pulmonary sarcoidosis. To assess the potential immunogenicity of multiple ascending doses of ATYR1923 in patients with pulmonary sarcoidosis. To characterize the pharmacokinetics (PK) of multiple ascending IV doses of ATYR1923 in patients with pulmonary sarcoidosis.

date/time interval

  • July 2019 - May 2022